Scientists develop novel animal model of neurobrucellosis

Neurobrucellosis is a severe long-term complication of brucellosis, one of the most common bacterial zoonotic diseases.

Psychedelic Research Bulletin: November 2023 – Psychedelic Alpha

This November, promising developments emerged across various areas of psychedelic research. To start, an innovative study explored novel routes of administering ayahuasca-analogue compounds, potentially improving

December 19, 2023

AHA 2024: CV effectiveness of GLP-1RA + Empagliflozin therapy

At the American Heart Association’s (AHA) 2024 Annual Scientific Sessions, which took place from 16 November to 18 November in Chicago, Ilinois, Eli Lilly and

November 19, 2024

Daiichi Sankyo, AstraZeneca say Enhertu works better than chemo in certain breast cancer patients

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.